308.44
5.12%
15.03
Madrigal Pharmaceuticals Inc (MDGL) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
29.75%
152.04
|
117.18 | 98.53 | 86.45 | 78.34 |
Interest Income/Expense |
3.35%
3.838
|
3.971 | 3.504 | 2.901 | 2.336 |
Operating Income/Loss |
29.75%
-152.04
|
-117.18 | -98.53 | -86.45 | -78.34 |
Income/Loss From Continuing Operations Before Tax |
31.51%
-147.54
|
-112.19 | -98.74 | -85.80 | -76.90 |
Income/Loss From Continuing Operations After Tax |
31.51%
-147.54
|
-112.19 | -98.74 | -85.80 | -76.90 |
Net Income/Loss
|
31.51%
-147.54
|
-112.19 | -98.74 | -85.80 | -76.90 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1.22%
20.00
|
19.76 | 18.48 | 18.31 | 18.19 |
Diluted Average Shares |
1.22%
20.00
|
19.76 | 18.48 | 18.31 | 18.19 |
Basic Earnings Per Share |
29.93%
-7.38
|
-5.68 | -5.34 | -4.69 | -4.23 |
Diluted Earnings Per Share |
29.93%
-7.38
|
-5.68 | -5.34 | -4.69 | -4.23 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):